Press
Healogix appoints Dawn Payne Vice President
Healogix, a full-service, custom marketing research consultancy for the pharmaceutical and biotechnology industries, announced today that Dawn Payne has been appointed Vice President. ...
January 11th, 2012 Read MoreHealogix Names Tim Edbrooke President
Pharmaceutical Industry Veteran Plans for Marketing Research Company's Next Growth Phase. ...
November 18th, 2011 Read MoreNew From Healogix – Adaptive Toolbox
Healogix is very excited to announce the launch of its newest product, Adaptive Toolbox. This is a completely new ...
October 13th, 2011 Read MoreTim O’Rourke, CRO presenting at the Fifth Annual PMRG Institute on October 18
In line with the Institute’s theme of “New Methods and New Mindsets”, Tim will be presenting a new approach ...
September 21st, 2011 Read MorePM360: Don’t Just Think ‘Customer’: Think ‘Customer’s Customer’
In a byline article, CEO Harris Kaplan talks about the Difference EngineTM from Healogix and how this proprietary approach can be used to help companies ...
September 19th, 2011 Read MoreHarris Kaplan – Uncommon Innovator
Read more on Harris Kaplan in this excerpt from PharmaVOICE, Commanders & Chiefs section. ...
August 5th, 2011 Read MoreHarris Kaplan Named to PharmaVOICE 100
Harris Kaplan has been honored as one of the PharmaVOICE 100, an annual list from PharmaVOICE magazine of the most inspiring people in the life science industry. ...
August 5th, 2011 Read MoreHarris quoted in April issue of MM&M
Code Red for DTC? See Harris' comments on page 1 ...
April 14th, 2011 Read MoreHarris Kaplan quoted in Jan issue of MedAdNews
Harris cites united Healthcare's new tagline, "Health in Numbers as representing a defining change in the industry. ...
February 15th, 2011 Read MoreHarris Kaplan in Nov/Dec PharmaVoice: Year in Preview “Trends: What’s Old is New Again”
See Harris' comments outlined in red. ...
January 18th, 2011 Read MoreOffice: 215.863.8160 | Fax: 215.830.5051 | Email: info@healogix.com
Marketing Research and Consulting for the Pharma and Biotech Industries